Call: 08071280193
Send Inquiry100mg Erlotinib Tablets IP
100mg Erlotinib Tablets IP Specification
- Pacakaging (Quantity Per Box)
- 30 tablets per box
- Life Span
- 24 months from manufacturing date
- Brand Name
- Erlotec 100 or as per brand availability
- Salt Composition
- Erlotinib Hydrochloride
- Origin of Medicine
- India
- Indication
- For treatment of locally advanced or metastatic non-small cell lung cancer and pancreatic cancer
- Packaging Type
- Blister pack in carton box
- Dosage Form
- Tablet
- Drug Type
- Anticancer medication, Prescription only anti-cancer medication
- Ingredients
- Erlotinib Hydrochloride 100mg
- Physical Form
- Film-coated tablet, Tablet
- Function
- Tyrosine kinase inhibitor, Anti-cancer therapy, EGFR tyrosine kinase inhibitor
- Recommended For
- Non-small cell lung cancer (NSCLC), pancreatic cancer
- Dosage
- As prescribed by physician; typically one 100mg tablet daily
- Dosage Guidelines
- Take on an empty stomach, at least one hour before or two hours after eating
- Suitable For
- Adults, Adults
- Quantity
- 30 Tablets per box
- Storage Instructions
- Store below 30C, protect from moisture and light
- Prescription/Non Prescription
- Prescription
- Administration Route
- Oral
- Side Effects
- Rash, diarrhea, loss of appetite, fatigue (Refer to full prescribing information)
- Color
- White to off-white
- Markings
- May include strength or brand identification
- Therapeutic Class
- Antineoplastic agents
- ATC Code
- L01EB02
- Minimum Order Quantity
- One box (30 tablets)
- Shape
- Round, biconvex
100mg Erlotinib Tablets IP Trade Information
- Minimum Order Quantity
- 10 Boxes
- Payment Terms
- Cash Against Delivery (CAD), Cash on Delivery (COD), Cash in Advance (CID)
- Supply Ability
- 100 Boxes Per Month
- Delivery Time
- 5-7 Days
- Main Domestic Market
- All India
About 100mg Erlotinib Tablets IP
New release: Erlotec 100 (or equivalent brand) 100mg Erlotinib Tablets IP offers an acclaimed, ineffable advancement in anti-cancer therapy. As an eminent tyrosine kinase inhibitor within the antineoplastic class (ATC Code: L01EB02), this splendiferous medicine is prescribed for adults battling non-small cell lung cancer (NSCLC) or pancreatic cancer. Each white to off-white, round, biconvex, film-coated tablet contains Erlotinib Hydrochloride 100mg. Price cuts now available for a minimum purchase of one box (30 tablets). Administer orally on an empty stomach, following physician's guidance. Store under 30C, shielded from moisture and light.
Key Use: Advanced Cancer Care for Adults
100mg Erlotinib Tablets IP are primarily used for the treatment of locally advanced or metastatic non-small cell lung cancer (NSCLC) and pancreatic cancer. Designed exclusively for adult patients, its eminent role as an oral EGFR tyrosine kinase inhibitor makes it essential in targeted anti-cancer therapy. Usage demands strict prescription by a qualified physician, with the common regimen involving once-daily administration, ensuring optimal therapeutic outcomes.
Certifications, Payment, and Domestic Distribution
Our 100mg Erlotinib Tablets IP meet Indian and international pharmaceutical standards, ensuring ineffable confidence in quality. Expenditure is streamlined via multiple payment terms, facilitating hassle-free handover and order completion. Meticulously packaged in blister packs and delivered in carton boxes, the product is available across all major domestic markets within India, providing broad access and secure handling throughout distribution chains.
Key Use: Advanced Cancer Care for Adults
100mg Erlotinib Tablets IP are primarily used for the treatment of locally advanced or metastatic non-small cell lung cancer (NSCLC) and pancreatic cancer. Designed exclusively for adult patients, its eminent role as an oral EGFR tyrosine kinase inhibitor makes it essential in targeted anti-cancer therapy. Usage demands strict prescription by a qualified physician, with the common regimen involving once-daily administration, ensuring optimal therapeutic outcomes.
Certifications, Payment, and Domestic Distribution
Our 100mg Erlotinib Tablets IP meet Indian and international pharmaceutical standards, ensuring ineffable confidence in quality. Expenditure is streamlined via multiple payment terms, facilitating hassle-free handover and order completion. Meticulously packaged in blister packs and delivered in carton boxes, the product is available across all major domestic markets within India, providing broad access and secure handling throughout distribution chains.
FAQ's of 100mg Erlotinib Tablets IP:
Q: How should 100mg Erlotinib Tablets IP be administered?
A: Erlotinib Tablets should be taken orally on an empty stomach, at least one hour before or two hours after eating, as prescribed by a physician.Q: What are the primary indications for using Erlotinib 100mg Tablets?
A: These tablets are recommended for adults with locally advanced or metastatic non-small cell lung cancer (NSCLC) and pancreatic cancer.Q: When should I consult my doctor about potential side effects?
A: Consult your doctor immediately if you experience persistent rash, diarrhea, loss of appetite, or fatigue while using Erlotinib. Always refer to the full prescribing information for detailed guidance.Q: Where are Erlotinib 100mg Tablets IP manufactured and supplied from?
A: The tablets are manufactured and supplied from India, adhering to stringent quality standards to ensure patient safety and efficacy.Q: What is the process for placing a minimum order?
A: A minimum order consists of one box containing 30 tablets. Orders can typically be placed through certified suppliers or authorized traders in India.Q: What are the key benefits of Erlotinib 100mg Tablets for eligible patients?
A: The eminent benefit of Erlotinib tablets is targeted anti-cancer activity, specifically inhibiting EGFR tyrosine kinase, thus slowing tumor growth and progression in NSCLC and pancreatic cancer.- Minimum Order Quantity
- 10 Boxes
- Supply Ability
- 100 Boxes Per Month
- Delivery Time
- 5-7 Days
- Main Domestic Market
- All India
Get Latest PriceTell us about your requirement
Price:
Quantity
Select Unit
- 50
- 100
- 200
- 250
- 500
- 1000+
Additional detail
Mobile number
Email
More Products in Pharmaceutical Tablet Category
25mg Eltrombopag Tablets
Minimum Order Quantity : 10 Boxes
Indication : Treatment of low platelet count in patients with chronic ITP, aplastic anemia, and chronic hepatitis C
Function : Other, Thrombopoietin receptor agonist, increases platelet production, Other, Thrombopoietin receptor agonist to increase platelet production
Ingredients : Eltrombopag Olamine
Origin of Medicine : India
Salt Composition : Eltrombopag Olamine 25 mg
250mg Gefitinib Tablets IP
Minimum Order Quantity : 10 Boxes
Indication : Treatment of locally advanced or metastatic nonsmall cell lung cancer with EGFR mutations
Function : Other, Anticancer (Epidermal Growth Factor Receptor Inhibitor), Other, Anticancer therapy (EGFR tyrosine kinase inhibitor)
Ingredients : Gefitinib
Origin of Medicine : India
Salt Composition : Gefitinib 250mg
50mg Dasatinib Tablets IP
Minimum Order Quantity : 10 Boxes
Indication : Treatment for Ph+ CML and Ph+ ALL
Function : Other, Anticancer, Tyrosine Kinase Inhibitor, Other, Anticancer/Targeted therapy
Ingredients : Dasatinib Monohydrate
Origin of Medicine : India
Salt Composition : Dasatinib Monohydrate equivalent to Dasatinib 50 mg
50mg Eltrombopag Tablets
Minimum Order Quantity : 10 Boxes
Indication : For patients with low platelet counts due to chronic ITP, Hepatitis C, or severe aplastic anemia
Function : Other, Thrombopoietin Receptor Agonist to increase platelet production, Other, Platelet Increasing Agent
Ingredients : Eltrombopag Olamine
Origin of Medicine : India
Salt Composition : Eltrombopag Olamine, equivalent to Eltrombopag 50mg
Contact Details
Mediexa Pharma
GST : 27ABFFM5974K1ZN
- B- N0 103, First Floor, station complex, Nerul E,Navi Mumbai - 400706, Maharashtra, India
- Phone :08071280193
Send Inquiry
Developed and Managed by Infocom Network Private Limited.
